排序方式: 共有21条查询结果,搜索用时 157 毫秒
1.
2.
3.
目的:从产品开发角度分析免疫细胞治疗类药物的发展现状和未来趋势。方法:检索科睿唯安(Clarivate Analytics)的Cortellis数据库的数据,利用定量分析法和对比分析法对检索结果进行分析。结果:目前已有2种免疫细胞治疗类药物上市,1种免疫细胞治疗类药物处于预注册阶段,4种药物处于临床Ⅲ期,同时大量处于临床Ⅱ/Ⅰ期药物显示未来市场上将有更多免疫细胞治疗类药物。产品交易方面,目前在免疫细胞治疗类药物的商业交易也趋向频繁。通过列举分析目前已发生的交易金额前十的交易,发现其中药物开发及商业化许可是最主要的交易模式。结论:目前免疫细胞治疗类药物市场尚处于起步阶段,但随着未来技术的不断发展改进,相信未来有更多的药物进入商用市场,为癌症及其他疾病的治疗提供新的契机。 相似文献
4.
正对2018年1~2月新公开的专利进行分析发现,肿瘤抗体治疗技术领域的专利主要包括两个方面。一是新靶点抗体的研发,包括针对CLDN6、CD3、CLDI8、PD-L1、OX40等的肿瘤抗体。二是双特异性抗体的研发, 相似文献
5.
6.
7.
8.
Objective: To construct an indicator model for stem cell patent evaluation and to analyze the factors affecting stem cell patent transfer and transformation in real scenarios besides the indicators.Methods:Based on the Patent Value Analysis Indicator System edited by China Technology Exchange, a patent evaluation system suitable for stem cells patents was constructed. The weight was determined by AHP, and the operability of the indicator model was verified by case analysis.Results:Based on the technical characteristics of stem cell technologies and operability, an indicator system for evaluating stem cell patents was constructed, which included three first-level indicators including technical value, market value and legal value, and nine second-level indicators such as technological advancement, technological maturity, technological cost, et al. Technological advancement, technological maturity, policy adaptability and market demand were the four most influential indicators for the valuation of stem cell patents. In the analysis of other factors, the core advantage of the stem cell technologies was the key to affect the transformation of stem cell patents. In addition, technical feasibility, quality control and long-term benefits also had important impact on the successful transfer and transformation of stem cell technologies.Conclusion:The patent value evaluation model and factor analysis established can be used in stem cell patent evaluation, which is helpful to promote the effective development and industrialization of the patent technology. 相似文献
9.
10.
目的:通过全球细胞治疗CMO/CDMO行业发展现状和主要企业进行分析,揭示CMO/CDMO行业发展存在的质量评估问题,提出质量评估相关建议。方法:利用定量分析法和对比分析法进行分析,揭示全球免疫细胞和干细胞治疗产品开发现状和细胞治疗CMO/CDMO行业发展现状。结果:随着细胞治疗行业的发展,越来越多机构显示对细胞治疗CMO/CDMOS行业的兴趣,其通过创建、收购、投资等方式介入进来。目前已经确定提供合同细胞或基因治疗制造服务的48家公司。结论:细胞治疗行业发展导致了CMO/CDMOS合同制造协议的繁荣,鉴于细胞治疗的特殊性和复杂性,对细胞治疗CMO/CDMO质量评估也充满挑战。 相似文献